Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06544798 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 120 to 276
    • Primary and study completion dates: Feb 2031 to Feb 2032
    • Study sites: 1 to 8
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
MeiraGTx, LLC
5 trials monitored
See 1 trial at risk
This study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.
Trial Details
NCT Number NCT06544798
Lead Sponsor MeiraGTx, LLC
Conditions
(from sponsor)		 Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Related terms Lymphoma, Follicular
Enrollment 276 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov